首站-论文投稿智能助手
典型文献
Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
文献摘要:
Non-alcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver disease worldwide. It refers to a range of liver conditions affecting people who drink little or no alcohol. NAFLD comprises non-alcoholic fatty liver and non-alcoholic steatohepatitis (NASH), the more aggressive form of NAFLD. NASH is featured by steatosis, lobular inflammation, hepatocyte injury, and various degrees of fibrosis. Although much progress has been made over the past decades, the pathogenic mechanism of NAFLD remains to be fully elucidated. Hepatocyte nuclear factor 4α (HNF4α) is a nuclear hormone receptor that is highly expressed in hepatocytes. Hepatic HNF4α expression is markedly reduced in NAFLD patients and mouse models of NASH. HNF4α has been shown to regulate bile acid, lipid, glucose, and drug metabolism. In this review, we summarize the recent advances in the understanding of the pathogenesis of NAFLD with a focus on the regulation of HNF4α and the role of hepatic HNF4α in NAFLD. Several lines of evidence have shown that hepatic HNF4α plays a key role in the initiation and progression of NAFLD. Recent data suggest that hepatic HNF4α may be a promising target for treatment of NAFLD.
文献关键词:
Nonalcoholic fatty liver disease;Hepatocyte nuclear factor 4α;Lipogenesis;Inflammation;Fibrosis;Liver;Lipotoxicity;Apoptosis
作者姓名:
Pan Xiaoli;Zhang Yanqiao
作者机构:
Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA
引用格式:
[1]Pan Xiaoli;Zhang Yanqiao-.Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease)[J].中华医学杂志(英文版),2022(10):1172-1181
A类:
Lipogenesis,Lipotoxicity
B类:
Hepatocyte,nuclear,pathogenesis,fatty,liver,disease,NAFLD,emerging,most,common,chronic,worldwide,It,refers,range,conditions,affecting,people,who,drink,little,comprises,steatohepatitis,NASH,more,aggressive,form,featured,by,steatosis,lobular,inflammation,injury,various,degrees,fibrosis,Although,much,has,been,made,over,past,decades,pathogenic,mechanism,remains,fully,elucidated,HNF4,hormone,receptor,that,highly,expressed,hepatocytes,Hepatic,expression,markedly,reduced,patients,mouse,models,shown,regulate,bile,acid,lipid,glucose,drug,metabolism,this,review,we,summarize,recent,advances,understanding,focus,regulation,role,hepatic,Several,lines,evidence,have,plays,key,initiation,progression,Recent,data,suggest,may,promising,target,treatment,Nonalcoholic,Inflammation,Fibrosis,Liver,Apoptosis
AB值:
0.549872
相似文献
Establishment and characterization of a new cell culture system for hepatitis B virus replication and infection
Yingying Song;Shuyu Shou;Huimin Guo;Zixiang Gao;Nannan Liu;Yang Yang;Feifei Wang;Qiang Deng;Jing Liu;Youhua Xie-Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS)and Department of Medical Microbiology and Parasitology,School of Basic Medical Sciences,Shanghai Institute of Infectious Diseases and Biosecurity,Shanghai Medical College,Fudan University,Shanghai,200032,China;Institute for Hepatology,National Clinical Research Center for Infectious Disease,Shenzhen Third People's Hospital,Shenzhen,518112,China;The Second Affiliated Hospital,School of Medicine,Southern University of Science and Technology,Shenzhen,518112,China;Shanghai Key Laboratory of Medical Epigenetics,Institutes of Biomedical Sciences,School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,200032,China;Children's Hospital,Fudan University,Shanghai,201102,China
New definition of metabolic dysfunction-associated fatty liver disease with elevated brachial-ankle pulse wave velocity and albuminuria:a prospective cohort study
Jialu Wang;Shanshan Liu;Qiuyu Cao;Shujing Wu;Jingya Niu;Ruizhi Zheng;Lizhan Bie;Zhuojun Xin;Yuanyue Zhu;Shuangyuan Wang;Hong Lin;Tiange Wang;Min Xu;Jieli Lu;Yuhong Chen;Yiping Xu;Weiqing Wang;Guang Ning;Yu Xu;Mian Li;Yufang Bi;Zhiyun Zhao-Department of Endocrine and Metabolic Diseases,Shanghai Institute of Endocrine and Metabolic Diseases,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Shanghai National Clinical Research Center for Metabolic Diseases,Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China,Shanghai Key Laboratory for Endocrine Tumor,State Key Laboratory of Medical Genomics,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Clinical Trials Center,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
Zhi-yong Xie;Wei Dong;Li Zhang;Meng-jie Wang;Zhen-meng Xiao;Yu-hua Zhang;Wan-xin Shi;Ying Huang;Yan Yang;Cui-li Li;Lei Fu;Xing-chen Zhao;Rui-zhao Li;Zhi-lian Li;Yuan-han Chen;Zhi-ming Ye;Shuang-xin Liu;Zheng Dong;Xin-ling Liang-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Division of Nephrology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;School of Medicine,South China University of Technology,Guangzhou 510006,China;Department of Cellular Biology and Anatomy,Medical College of Georgia at Augusta University,Augusta,GA,USA;Department of Medical Research,Charlie Norwood Veterans Affairs Medical Center,Augusta,GA,USA
Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells
Hao Shen;Han Yu;Qian-yu Li;Ya-ting Wei;Jing Fu;Hui Dong;Dan Cao;Lin-na Guo;Lei Chen;Yuan Yang;Ying Xu;Meng-chao Wu;Hong-yang Wang;Yao Chen-International Cooperation Laboratory on Signal Transduction,National Center for Liver Cancer,Ministry of Education Key Laboratory on signaling Regulation and Targeting Therapy of Liver Cancer,Shanghai Key Laboratory of Hepato-biliary Tumor Biology,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University/NAVAL Medical University,Shanghai 200433,China;Department of Pathology,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Metabolism and Integrative Biology,Fudan University,Shanghai 200438,China;Third Department of Hepatic Surgery,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200433,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。